It indicates that HDAC-mediated epigenetic programming also involves other beneficial mechanisms to combat against endothelial dysfunction beyond HDAC6-mediated control of MT dynamics that needs future attention. The gene discussed is HDAC6; the disease is endothelial dysfunction.